Multiple insiders secured a larger position in Cartesian Therapeutics, Inc. ( NASDAQ:RNAC ) shares over the last ...

Mizuho Securities analyst Uy Ear has maintained their bullish stance on RNAC stock, giving a Buy rating today. Uy Ear has given his Buy rating ...

Analyst Gil Blum from Needham maintained a Buy rating on Cartesian Therapeutics (RNAC – Research Report) and keeping the price target at ...

Cartesian Therapeutics, Inc. (RNAC) shares soared 26.9% in the last trading session to close at $22.82. The move was backed by solid volume with far more shares changing hands than in a normal session ...

The former British prime minister has a talent for the acerbic put-down. The EU’s Brexit negotiator is “prickly, Cartesian ...

The release of pressure should cause it to float back up again. What’s happening here? Scientists have known about the Cartesian Diver toy for hundreds of years. Raffaelo Maggiotti, a student of ...

Syncfusion, Inc., the enterprise technology partner of choice, announces the release of its first set of open-source .NET MAUI controls. The controls are shipping as NuGet packages and will be ...

Small cap companies have underperformed their large-cap peers in the past few years as most of them have struggled in a ...

Following the inspiring student-led revolution, a renewed hope emerged that Bangladesh could finally realize its aspirations ...

特殊目的收购公司Cartesian Growth Corporation II (NASDAQ:RENEU)周二宣布，已与风险减缓产品板块的一家未具名实体达成初步协议。如果最终达成，这项潜在的业务合并预计将使该公司成为市场领导者，2025年的备考调整后EBITDA将超过1亿美元。 周一签署的不具约束力的意向书标志着Cartesian Growth Corp II首次业务合并的第一步。然而，该公司强 ...

根据向美国证券交易委员会(SEC)提交的8-K文件，空白支票公司Cartesian Growth Corporation II (NASDAQ:RENE)已修改其信托协议，允许将资金存入计息银行存款账户。这一变更于2024年10月7日生效，使公司此前投资于美国政府国债的信托账户资金能够存入计息的银行活期存款账户。 这项对投资管理信托协议的修订是与受托人Continental Stock Trans ...

The Octoberfest is a noble tradition in category theory: a low-key, friendly conference for researchers to share their work and thoughts. This year it’s on Saturday October 26th and Sunday October ...